Corteva, Inc. (LON:0A1W)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 41.39B +15.0% |
| Revenue (ttm) | 13.42B +3.7% |
| Net Income | 760.48M -28.0% |
| EPS | 1.13 -26.4% |
| Shares Out | n/a |
| PE Ratio | 54.43 |
| Forward PE | 21.75 |
| Dividend | 0.54 (0.88%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 15 |
| Open | 72.28 |
| Previous Close | 73.18 |
| Day's Range | 72.28 - 72.28 |
| 52-Week Range | 51.35 - 78.58 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profit... [Read more]
Financial Performance
In 2025, Corteva's revenue was $17.40 billion, an increase of 2.92% compared to the previous year's $16.91 billion. Earnings were $1.09 billion, an increase of 20.62%.
Financial numbers in USD Financial StatementsNews
Corteva initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of Corteva (CTVA) with a Sector Weight rating and no price target The firm rolled out coverage on 19 chemical and agriculture companies, with nine Overweights, nine…
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…
Corteva, Globachem to form joint venture
Corteva (CTVA) and Globachem N.V., a private company based in Belgium specializing in developing and globally marketing a wide range of crop protection products, announced that they have entered into…
Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions
JV to amplify both companies' complementary expertise to develop, scale, deliver differentiated crop protection solutions in high-growth markets INDIANAPOLIS and SINT-TRUIDEN, Belgium, Sept. 9, 2026 /...
Corteva’s Vylor announces launch of Vylor Edge
Vylor, the company that will spin-off from Corteva (CTVA) on October 1, 2026, announced the launch of Vylor Edge, a new investment platform made to help accelerate the development of…
Vylor Launches Vylor Edge, New Investment Platform for Global Agriculture Innovation
Platform to accelerate investment in next generation ag-tech innovation JOHNSTON, Iowa, Sept. 3, 2026 /PRNewswire/ -- Vylor, the advanced seed and genetics company that will spin-off from Corteva on ...
Vylor Launches a New Era in Corn: Industry-First Yield and Yield Stability Trait, Advanced Insect Control to Deliver Step-Change in Production, Farmer Profitability
Company to Lock in Market Leadership, Deliver $2 Billion in Incremental Revenue by 2035 INDIANAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc. (N...
Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
INDIANAPOLIS, Aug. 20, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has received the early tender ...
Corteva price target lowered to $85 from $89 at UBS
UBS analyst Joshua Spector lowered the firm’s price target on Corteva (CTVA) to $85 from $89 and keeps a Neutral rating on the shares. Corteva has a more favorable setup…
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also know...
Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has commenced private offers to...
Corteva price target raised to $101 from $100 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised the firm’s price target on Corteva (CTVA) to $101 from $100 and keeps a Buy rating on the shares.
Corteva price target raised to $89 from $86 at UBS
UBS analyst Joshua Spector raised the firm’s price target on Corteva (CTVA) to $89 from $86.
Corteva price target raised to $83 from $77 at JPMorgan
JPMorgan raised the firm’s price target on Corteva (CTVA) to $83 from $77 and keeps a Neutral rating on the shares.
Corteva price target raised to $100 from $95 at BMO Capital
BMO Capital analyst Joel Jackson raised the firm’s price target on Corteva (CTVA) to $100 from $95 and keeps an Outperform rating on the shares. The market’s negative reaction to…
Corteva price target raised to $86 from $85 at Citi
Citi raised the firm’s price target on Corteva (CTVA) to $86 from $85 and keeps a Neutral rating on the shares.
Corteva Earnings Call Transcript: Q2 2026
Strong first-half 2026 results included 4% sales growth and 10% EBITDA growth, driven by robust execution in both seed and crop protection. Full-year guidance was raised, with the company on track for its planned separation and continued margin expansion, despite ongoing pricing pressure in select markets.
Corteva Slides: Q2 2026
Corteva has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Corteva Earnings release: Q2 2026
Corteva released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Corteva Quarterly report: Q2 2026
Corteva has published its Q2 2026 quarterly earnings report on July 31, 2026.
Corteva remains on-track to complete planned separation
Chuck Magro, Chief Executive Officer: “Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performa...
Corteva reports Q2 adjusted EPS $2.30, consensus $2.23
Reports Q2 revenue $6.38B, consensus $6.6B.